1. GSK aims to make 1B doses of vaccine booster for multiple COVID-19 partners — Protalix and Chiesi get close to potential Fabry disease treatment approval — AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica deal — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Former CMO

Discussion in 'Medivation' started by anonymous, Sep 30, 2015 at 8:56 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    It is very interesting to see L.S. Is finally leaving.
    End of an Era. End of a dictatorship. She has sold many shares, now that she will no longer be an officer in the company, she will not be tied to SEC rules and can dump most if not all her shares while shares are still high before Abiraterone goes generic by next year.
    After all she claimed, she always cared about her pocket than patients. Thank GOD she will be gone soon.
     

  2. anonymous

    anonymous Guest

    The company would not have been so successful without her. David would have fallen face forward. She made this place not him. Her leaving justifies Medivation has no future. The stock will only continue to drop and sales will continue to decrease.
     
  3. anonymous

    anonymous Guest

    Timing of her retirement is important. SEC should look at her financial activities vs what MDVN has been pushing as label expansions trials that we all know does not makes any sense.
    M.H., is a development person and I am not sure he has business acumen required by a CMO.
     
  4. anonymous

    anonymous Guest

    does anyone see a pattern here??? 3rd female exec to lose her seat at the table in just over a year and be replaced by a man.
     
  5. anonymous

    anonymous Guest

    Yes I see. DH likes male servants that will do anything he says and the women stand up to his arrogant attitude. The last 3 men he hired have done nothing to increase sales, make change and motivate our culture.
     
  6. anonymous

    anonymous Guest

    Of course they are following their partner, AS, Chauvinitic attitude. It will not get better, that is for sure.
     
  7. anonymous

    anonymous Guest

     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    Just go to the SEC site and you will see how many shares each officer, including LS, owned, sold while there and thereafter. She is resting comfortably and laughing at this situation. She lied to Physicians, FDA, patients and others regarding possibility of Xtandi's success, only to keep the market excited and shares higher than what they should be, this window, gave her and other executives a great window to execute their shares and options at the highest. In a meanwhile, we are stock with limited shares that we can sell in specific periods each year and are at the mercy of others! She and some other executives should go to jail for their actions.